These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3413542)

  • 21. [Complications of indirect lymphotropic therapy in patients with suppurative wounds].
    Pavlov VV; Pleshakov VP; Maĭborodin IV
    Khirurgiia (Mosk); 1999; (2):37-8. PubMed ID: 10081252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The arteriolymphatic administration of antibiotics in treating patients with suppurative-inflammatory diseases of the abdominal cavity organs].
    Buianov VM; Danilov KIu; Kharitonov SV
    Khirurgiia (Mosk); 1998; (8):27-30. PubMed ID: 9753933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Perfusion of the lymphatic system in intensive therapy].
    Stashchuk VF
    Anesteziol Reanimatol; 1983; (3):56-8. PubMed ID: 6614571
    [No Abstract]   [Full Text] [Related]  

  • 24. [The progressive trends and outlook for the clinical use of endolymphatic chemotherapy (a review of the literature and the authors' own data)].
    Datsun AI; Zabudkin AF; Bondar HV; Holotiuk IA
    Lik Sprava; 1994; (9-12):23-7. PubMed ID: 7604577
    [No Abstract]   [Full Text] [Related]  

  • 25. [The clinico-physiological validation of the use of the endolymphatic route for antibiotic administration for preventing the translocation of intestinal microflora during the treatment of sepsis patients].
    Maksimenko VI; Treshchinskiĭ AI; Shlapak IP; Vasil'ev GA; Bondar' MV; Kharchenko LA; Iakub AA
    Lik Sprava; 1992 Jul; (7):56-61. PubMed ID: 1448990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Indirect endolymphatic antibiotic therapy in suppurative-inflammatory diseases in children].
    Komarov NV; Komlev PN
    Klin Khir (1962); 1991; (6):71. PubMed ID: 1942817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined endolymphatic therapy in patients with diffuse peritonitis].
    Sheremet PF; Turianitsa IM; Shpriakha IaS
    Klin Khir (1962); 1994; (4):28-30. PubMed ID: 7799581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Administration of medications via a lymphatic vessel in the treatment of diffuse peritonitis and sepsis].
    Pristaĭko IaI
    Vestn Khir Im I I Grek; 1985 Jan; 134(1):68-70. PubMed ID: 3992808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endolymphatic therapy and current detoxication methods in the treatment of peritonitis].
    Petrov SV; Bubnova NA; Marchenko AV; Levitina EI; Smolina EN
    Vestn Khir Im I I Grek; 1996; 155(5):30-2. PubMed ID: 9123751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endolymphatic antibiotic therapy of an appendicular infiltrate].
    Panchenkov RT; Iarema IV; Lumer MG; Korobkov EE; Mikhaĭlov II
    Khirurgiia (Mosk); 1985 Sep; (9):95-9. PubMed ID: 4057897
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dynamics of immune status in patients with phlegmons of the maxillofacial area during endolymphatic antibiotic therapy]].
    Tereshenko AE; Agapov VS; Kuznetsov EA; Tsarev VN; Tarasenko SV
    Stomatologiia (Mosk); 2000; 79(6):35-7. PubMed ID: 11186565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endolymphatic antegrade infusion of drugs in the treatment of suppurative-inflammatory diseases].
    Sinenchenko GI
    Vestn Khir Im I I Grek; 1988 Oct; 141(10):143-5. PubMed ID: 3071893
    [No Abstract]   [Full Text] [Related]  

  • 33. [Endolymphatic antibiotic therapy in the prevention and treatment of purulent-septic complications in vascular surgery].
    Zatevakhin II; Drozdov SA; Gorbenko IuF; Pshenichnyĭ VN; Komrakov VE
    Klin Khir (1962); 1990; (3):30-2. PubMed ID: 2366421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endolymphatic antibiotic therapy of inflammatory infiltrates of the abdominal cavity].
    Ermolov AS; Udovskiĭ EE; Grigorian AR
    Sov Med; 1984; (12):34-6. PubMed ID: 6523230
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children.
    Hussain S; Gomez MM; Wludyka P; Chiu T; Rathore MH
    Clin Pediatr (Phila); 2007 Apr; 46(3):247-51. PubMed ID: 17416881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Catheters for endolymphatic drug therapy].
    Tsyb AF; Mukhamedzhanov IKh; Dergachev AI
    Vestn Khir Im I I Grek; 1988 Mar; 140(3):127-8. PubMed ID: 3407068
    [No Abstract]   [Full Text] [Related]  

  • 37. [Endolymphatic antibiotic therapy in acute inflammatory diseases in urological practice].
    Slutskin IM; Dolgin MR
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):49-52. PubMed ID: 3947053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of endolymphatic antibiotic therapy on the status of cellular immunity in peritonitis].
    Toskin KD; Starosek VN; Popov SN; Lebedev AI
    Klin Khir (1962); 1991; (4):7-9. PubMed ID: 1881089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intensive intralymphatic and lymphotropic therapy in children].
    Zhdanov GG; Goremykin IV; Savinov TKh
    Anesteziol Reanimatol; 1994; (3):50-4. PubMed ID: 7521583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics and clinical evaluation of lymphotropic antibiotic therapy].
    Buianov VM; Danilov KIu; Brodinova NS; Kharitonov SV
    Sov Med; 1987; (9):41-5. PubMed ID: 3423989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.